B/BE/21/BVW5 - Fiche d'information destinée au public (préparée par le notifiant)

Trial reference: 
A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)